Pharmatest would like to invite you to the live Webinar on Tuesday 4th May at 4 pm BST (6 pm EEST). This must-attend event will focus To Overcome the Challenges in Cancer Treatment – From Bone Metastasis to Nanotechnology and will be presented by two experts within the field.
The complexity of the cross-talk between tumor and bone microenvironment is characteristic of the metastatic bone disease occurring in various cancers, such as breast and prostate cancer and multiple myeloma. Animal models can be used to evaluate the mode-of-action and efficacy of new targeted therapies in bone metastasis.
Nanomedicine enables new opportunities for targeted drug delivery thus reducing the adverse effects of treatment on healthy cells. Use of nanotechnology has the potential to change the course of diagnostics and treatment of cancer by integrating the unique characteristics of nanoparticles combined with strategies to modify the microenvironment.
Introduction by Pharmatest Services
Jukka Rissanen, PhD, CEO, Pharmatest Services
PRESENTATION 1: Breaking the vicious crosstalk – Using preclinical models to identify compounds to combat metastatic bone disease
Sanna Käkönen, PhD, Founder, CEO, Aurexel Lifesciences Ltd.; Adjunct Professor, Turun yliopisto – University of Turku
PRESENTATION 2: Extracellular vesicles in cancer
Joy Wolfram, PhD, Assistant Professor, Mayo Clinic; Board Member, Pharmatest Services
(Registration has been closed.)